BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 30242504)

  • 1. Value of adding dynamic contrast-enhanced MRI visual assessment to conventional MRI and clinical assessment in the diagnosis of complete tumour response to chemoradiotherapy for rectal cancer.
    Gollub MJ; Blazic I; Felder S; Knezevic A; Gonen M; Garcia-Aguilar J; Paty PP; Smith JJ
    Eur Radiol; 2019 Mar; 29(3):1104-1113. PubMed ID: 30242504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRI and diffusion-weighted MRI to diagnose a local tumour regrowth during long-term follow-up of rectal cancer patients treated with organ preservation after chemoradiotherapy.
    Lambregts DM; Lahaye MJ; Heijnen LA; Martens MH; Maas M; Beets GL; Beets-Tan RG
    Eur Radiol; 2016 Jul; 26(7):2118-25. PubMed ID: 26518582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of Clinical Complete Response After Chemoradiation for Rectal Cancer with Digital Rectal Examination, Endoscopy, and MRI: Selection for Organ-Saving Treatment.
    Maas M; Lambregts DM; Nelemans PJ; Heijnen LA; Martens MH; Leijtens JW; Sosef M; Hulsewé KW; Hoff C; Breukink SO; Stassen L; Beets-Tan RG; Beets GL
    Ann Surg Oncol; 2015 Nov; 22(12):3873-80. PubMed ID: 26198074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Locally advanced rectal cancer: is diffusion weighted MRI helpful for the identification of complete responders (ypT0N0) after neoadjuvant chemoradiation therapy?
    Sassen S; de Booij M; Sosef M; Berendsen R; Lammering G; Clarijs R; Bakker M; Beets-Tan R; Warmerdam F; Vliegen R
    Eur Radiol; 2013 Dec; 23(12):3440-9. PubMed ID: 23832319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiparametric MRI in the assessment of response of rectal cancer to neoadjuvant chemoradiotherapy: A comparison of morphological, volumetric and functional MRI parameters.
    Hötker AM; Tarlinton L; Mazaheri Y; Woo KM; Gönen M; Saltz LB; Goodman KA; Garcia-Aguilar J; Gollub MJ
    Eur Radiol; 2016 Dec; 26(12):4303-4312. PubMed ID: 26945761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRI for Assessing Response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer Using DCE-MR and DW-MR Data Sets: A Preliminary Report.
    Petrillo M; Fusco R; Catalano O; Sansone M; Avallone A; Delrio P; Pecori B; Tatangelo F; Petrillo A
    Biomed Res Int; 2015; 2015():514740. PubMed ID: 26413528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Locally advanced rectal cancer: qualitative and quantitative evaluation of diffusion-weighted magnetic resonance imaging in restaging after neoadjuvant chemo-radiotherapy.
    Napoletano M; Mazzucca D; Prosperi E; Aisa MC; Lupattelli M; Aristei C; Scialpi M
    Abdom Radiol (NY); 2019 Nov; 44(11):3664-3673. PubMed ID: 31004202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How to Combine Diffusion-Weighted and T2-Weighted Imaging for MRI Assessment of Pathologic Complete Response to Neoadjuvant Chemoradiotherapy in Patients with Rectal Cancer?
    Jang JK; Lee CM; Park SH; Kim JH; Kim J; Lim SB; Yu CS; Kim JC
    Korean J Radiol; 2021 Sep; 22(9):1451-1461. PubMed ID: 34132075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Predictive value of combination of MRI tumor regression grade and apparent diffusion coefficient for pathological complete remission after neoadjuvant treatment of locally advanced rectal cancer].
    Xu N; Huang FC; Li WL; Luan X; Jiang YM; He B
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Apr; 24(4):359-365. PubMed ID: 33878826
    [No Abstract]   [Full Text] [Related]  

  • 10. Endoscopy and MRI for restaging early rectal cancer after neoadjuvant treatment.
    Stijns RCH; Leijtens J; de Graaf E; Bach SP; Beets G; Bremers AJA; Beets-Tan RGH; de Wilt JHW
    Colorectal Dis; 2023 Feb; 25(2):211-221. PubMed ID: 36104011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Pattern-Based Approach Combining Tumor Morphology on MRI With Distinct Signal Patterns on Diffusion-Weighted Imaging to Assess Response of Rectal Tumors After Chemoradiotherapy.
    Lambregts DMJ; Delli Pizzi A; Lahaye MJ; van Griethuysen JJM; Maas M; Beets GL; Bakers FCH; Beets-Tan RGH
    Dis Colon Rectum; 2018 Mar; 61(3):328-337. PubMed ID: 29369900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffusion-weighted MRI for selection of complete responders after chemoradiation for locally advanced rectal cancer: a multicenter study.
    Lambregts DM; Vandecaveye V; Barbaro B; Bakers FC; Lambrecht M; Maas M; Haustermans K; Valentini V; Beets GL; Beets-Tan RG
    Ann Surg Oncol; 2011 Aug; 18(8):2224-31. PubMed ID: 21347783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic accuracy of state-of-the-art rectal MRI sequences for the diagnosis of extramural vascular invasion in locally advanced rectal cancer after preoperative chemoradiotherapy: dos or maybes?
    Crimì F; Angelone R; Corso A; Bao QR; Cabrelle G; Vernuccio F; Spolverato G; Pucciarelli S; Quaia E
    Eur Radiol; 2023 Oct; 33(10):6852-6860. PubMed ID: 37115215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-modal radiomics model to predict treatment response to neoadjuvant chemotherapy for locally advanced rectal cancer.
    Li ZY; Wang XD; Li M; Liu XJ; Ye Z; Song B; Yuan F; Yuan Y; Xia CC; Zhang X; Li Q
    World J Gastroenterol; 2020 May; 26(19):2388-2402. PubMed ID: 32476800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of dynamic perfusion magnetic resonance imaging in patients with local advanced rectal cancer.
    Ippolito D; Drago SG; Pecorelli A; Maino C; Querques G; Mariani I; Franzesi CT; Sironi S
    World J Gastroenterol; 2020 May; 26(20):2657-2668. PubMed ID: 32523318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T2-weighted signal intensity-selected volumetry for prediction of pathological complete response after preoperative chemoradiotherapy in locally advanced rectal cancer.
    Kim S; Han K; Seo N; Kim HJ; Kim MJ; Koom WS; Ahn JB; Lim JS
    Eur Radiol; 2018 Dec; 28(12):5231-5240. PubMed ID: 29858637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI and Diffusion-weighted MRI Volumetry for Identification of Complete Tumor Responders After Preoperative Chemoradiotherapy in Patients With Rectal Cancer: A Bi-institutional Validation Study.
    Lambregts DM; Rao SX; Sassen S; Martens MH; Heijnen LA; Buijsen J; Sosef M; Beets GL; Vliegen RA; Beets-Tan RG
    Ann Surg; 2015 Dec; 262(6):1034-9. PubMed ID: 25211270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of diffusion kurtosis magnetic resonance imaging for assessing treatment response of neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    Yu J; Xu Q; Song JC; Li Y; Dai X; Huang DY; Zhang L; Li Y; Shi HB
    Eur Radiol; 2017 May; 27(5):1848-1857. PubMed ID: 27631106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simple measurements on diffusion-weighted MR imaging for assessment of complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    Cai PQ; Wu YP; An X; Qiu X; Kong LH; Liu GC; Xie CM; Pan ZZ; Wu PH; Ding PR
    Eur Radiol; 2014 Nov; 24(11):2962-70. PubMed ID: 25038851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffusion-weighted MRI to assess response to chemoradiotherapy in rectal cancer: main interpretation pitfalls and their use for teaching.
    Lambregts DMJ; van Heeswijk MM; Delli Pizzi A; van Elderen SGC; Andrade L; Peters NHGM; Kint PAM; Osinga-de Jong M; Bipat S; Ooms R; Lahaye MJ; Maas M; Beets GL; Bakers FCH; Beets-Tan RGH
    Eur Radiol; 2017 Oct; 27(10):4445-4454. PubMed ID: 28409357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.